HomePortfoliosUS Quarterly Profit Take

US Quarterly Profit Take

Monthly Rebalancing
GBP
Moderate Risk
2.0yr backtest

Performance Summary

Total Return+26.20%
Annualized Return+12.35%
Volatility+10.23%
Sharpe Ratio1.01
Max Drawdown+15.48%

Holdings

Asset Allocation

Asset Class

Equity 70.0%Money Market 30.0%
Holdings Details
Diversified ETF portfolio blending 70% US equity exposure with 30% money market stability for a balanced core investment strategy.
AssetTypeAllocationTER
USEE.LSE
iShares US Equity Enhanced Active UCITS ETF USD (Acc)IE0009VWHAE6
ETF
70.0%0.2%
CSH2.LSE
Amundi Smart Overnight Return UCITS ETF GBP Hedged AccLU1230136894
ETF
30.0%0.1%
Total100.0%0.17%

Performance

Portfolio Value Over Time
Starting with £10,000 investment → now worth £12,619.72
Histogram of Monthly Returns
The portfolio had a positive return during 13 of the 25 months (52%)
Monthly Returns Heatmap
Best month: +6.2% • Worst month: -5.8% • Best year: 2025 (+9.1%) • Worst year: 2026 (+7.3%)
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-1.1%+0.9%-2.7%+6.2%+4.8%+0.7%-1.4%-----+7.3%
2025+3.0%-3.6%-5.8%-2.3%+4.6%+2.3%+5.1%-0.4%+2.9%+4.4%-0.6%-0.2%+9.1%
2024------+0.0%-0.6%+0.7%+2.9%+5.0%-0.2%+7.8%
> +2%
0% to +2%
-2% to 0%
< -2%
Drawdown Analysis
Maximum drawdown: +15.48% • The longest drawdown period lasted for 7 months and was between January 2025 and September 2025. It reached a trough of -15.5%.

Detailed Metrics

Returns
Total Return
+26.20%
Annualized Return
+12.35%
Avg Monthly Return
+0.98%
Risk
Volatility (Annual)
+10.23%
Max Drawdown
+15.48%
Positive Months
52%
Average Drawdown
-2.7%
Risk-Adjusted
Sharpe Ratio
1.01
Risk-free rate: 2.0%
Sortino Ratio
0.95
Downside risk adjusted
Return/Volatility
1.21
Calmar Ratio
0.80
Return/Max Drawdown
Ulcer Index
3.94
Drawdown depth & duration
Martin Ratio
0.03
Return/Ulcer Index
Backtest Configuration
Initial Investment
£10,000
Final Value
£12,619.72
Backtest Period
2024-07-31 to 2026-07-31
2.0 years
Rebalancing
monthly
Base Currency
GBP
US Quarterly Profit Take | +12.3% CAGR | ETF Backtest